Open Access

CTRP9 decreases high glucose‑induced trophoblast cell damage by reducing endoplasmic reticulum stress

  • Authors:
    • Lianxiao Zhang
    • Huiqing Ding
    • Yubo Shi
    • Duoyi Zhang
    • Xue Yang
  • View Affiliations

  • Published online on: March 28, 2022     https://doi.org/10.3892/mmr.2022.12701
  • Article Number: 185
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

C1q/TNF‑α‑related protein 9 (CTRP9) is downregulated in gestational diabetes mellitus (GDM) and may exert a protective effect against GDM, although its mechanism of action is yet to be elucidated. To investigate the specific role of CTRP9 in GDM, the human placental trophoblast cell line HTR8/SVneo was treated with high glucose (HG) to simulate the environment of GDM in vitro. The effects of CTRP9 on the HTR8/SVneo cells and endoplasmic reticulum (ER) stress were analyzed before and after CTRP9 overexpression using reverse transcription‑quantitative PCR and western blotting. The results obtained demonstrated that CTRP9 alleviated ER stress in the trophoblast cell line. After treating with the ER‑stress inducer tunicamycin, cell viability was investigated by performing Cell Counting Kit‑8, TUNEL and western blotting assays, which revealed that CTRP9 increased the activity of HTR8/SVneo cells induced by HG through the alleviation of ER stress. Subsequently, ELISA and western blotting assay results demonstrated that CTRP9 inhibited HG‑induced inflammation of the HTR8/SVneo cells by the reduction in ER stress. Finally, the detection of reactive oxygen species, nitric oxide (NO) synthase and NO levels confirmed that CTRP9 inhibited the oxidative stress of HTR8/SVneo cells induced by HG through the reduction of ER stress. Collectively, the results of the present study suggested that CTRP9 may decrease trophoblast cell damage caused by HG through the suppression of ER stress, and therefore, CTRP9 may potentially be a therapeutic target in the treatment of GDM.
View Figures
View References

Related Articles

Journal Cover

May-2022
Volume 25 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang L, Ding H, Shi Y, Zhang D and Yang X: CTRP9 decreases high glucose‑induced trophoblast cell damage by reducing endoplasmic reticulum stress. Mol Med Rep 25: 185, 2022.
APA
Zhang, L., Ding, H., Shi, Y., Zhang, D., & Yang, X. (2022). CTRP9 decreases high glucose‑induced trophoblast cell damage by reducing endoplasmic reticulum stress. Molecular Medicine Reports, 25, 185. https://doi.org/10.3892/mmr.2022.12701
MLA
Zhang, L., Ding, H., Shi, Y., Zhang, D., Yang, X."CTRP9 decreases high glucose‑induced trophoblast cell damage by reducing endoplasmic reticulum stress". Molecular Medicine Reports 25.5 (2022): 185.
Chicago
Zhang, L., Ding, H., Shi, Y., Zhang, D., Yang, X."CTRP9 decreases high glucose‑induced trophoblast cell damage by reducing endoplasmic reticulum stress". Molecular Medicine Reports 25, no. 5 (2022): 185. https://doi.org/10.3892/mmr.2022.12701